BGPKX
Price
$13.62
Change
+$0.03 (+0.22%)
Updated
Aug 15 closing price
Net Assets
171.12M
RERFX
Price
$62.46
Change
+$0.36 (+0.58%)
Updated
Aug 15 closing price
Net Assets
135.22B
Interact to see
Advertisement

BGPKX vs RERFX

Header iconBGPKX vs RERFX Comparison
Open Charts BGPKX vs RERFXBanner chart's image
Baillie Gifford Developed EAFE All Cap K
Price$13.62
Change+$0.03 (+0.22%)
VolumeN/A
Net Assets171.12M
American Funds EUPAC R5
Price$62.46
Change+$0.36 (+0.58%)
VolumeN/A
Net Assets135.22B
BGPKX vs RERFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BGPKX vs. RERFX commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BGPKX is a StrongBuy and RERFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERFX has more cash in the bank: 135B vs. BGPKX (171M). BGPKX pays higher dividends than RERFX: BGPKX (1.74) vs RERFX (0.92). BGPKX was incepted earlier than RERFX: BGPKX (8 years) vs RERFX (23 years). BGPKX (0.65) is less costly to investors than RERFX (0.52). RERFX is a more actively managed with annual turnover of: 35.00 vs. BGPKX (17.00). RERFX has a lower initial minimum investment than BGPKX: RERFX (250) vs BGPKX (10000000). RERFX annual gain was more profitable for investors over the last year : 8.58 vs. BGPKX (7.30). RERFX return over 5 years is better than : 14.11 vs. BGPKX (1.03).
BGPKXRERFXBGPKX / RERFX
Total Expense Ratio0.650.52125%
Annual Report Gross Expense Ratio0.650.52125%
Fund Existence8 years23 years-
Gain YTD10.55216.40064%
Front LoadN/AN/A-
Min. Initial Investment100000002504,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets171M135B0%
Annual Yield % from dividends1.740.92190%
Returns for 1 year7.308.5885%
Returns for 3 years10.8325.5942%
Returns for 5 years1.0314.117%
Returns for 10 yearsN/A33.85-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IQ1.990.08
+4.19%
iQIYI
IMDX2.40N/A
N/A
Insight Molecular Diagnostics Inc
AQST4.11N/A
N/A
Aquestive Therapeutics
EXEL38.31-0.16
-0.42%
Exelixis
TANH1.83-0.05
-2.66%
Tantech Holdings Ltd.